Position in BNTX
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$73,646,190
-$1,012,210 QoQ
Shares Held
791,469
-5.8% QoQ
Ownership
0.315%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#11
of 282 holders
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIRST TRUST ADVISORS LP holds $2,824,813,122 across 97 Biotechnology names. BNTX ranks #16 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
547,132 | $341,158,687 | |
| 2 | INCY |
Incyte Corp
|
1,587,996 | $180,015,226 | |
| 3 | CORT |
Corcept Therapeutics Inc
|
1,829,545 | $159,078,937 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
289,179 | $143,643,884 | |
| 5 | EXEL |
Exelixis, Inc.
|
2,543,353 | $138,383,836 | |
| 6 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
421,534 | $126,894,380 | |
| 7 | KRYS |
Krystal Biotech, Inc.
|
324,900 | $120,755,583 | |
| 8 | AXSM |
Axsome Therapeutics, Inc.
|
482,061 | $117,994,070 |
All Filings in BNTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $73,646,190 | 791,469 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $74,658,400 | 839,991 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,020,138 | 388,867 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $30,140,441 | 305,622 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $35,279,899 | 331,360 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $28,860,101 | 316,935 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $39,619,047 | 347,688 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $53,588,073 | 451,192 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $32,871,499 | 409,053 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $43,998,676 | 416,891 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $45,553,838 | 419,310 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $44,080,230 | 408,415 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $44,926,793 | 360,655 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $52,916,797 | 352,262 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $37,187,764 | 275,710 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $47,196,710 | 316,544 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $83,566,042 | 489,951 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $77,954,079 | 302,382 | Shares | Sole | 2022-02-08 | |
| 2021-09-30 | $100,899,560 | 369,609 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $22,649,715 | 101,169 | Shares | Sole | 2021-10-12 | |
| 2021-03-31 | $15,620,503 | 143,058 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||